Stocktwits on MSN1d
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last WeekHowever, a Stocktwits poll indicates retail traders remain skeptical, with some flagging it as a potential pump-and-dump risk ...
people with diabetes announced that safety and performance data from its first-in-human trial of its long-term continuous blood glucose ...
GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company’s ...
Other factors that can limit the accuracy of both CGM and CBGM values include inter-individual differences in the uptake and absorption of glucose after consuming a meal, blood flow differences ...
RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and ...
The company announced the successful completion of its first human clinical trial for its Continuous Blood Glucose Monitor (CBGM), a device that could eliminate both the accuracy limitations of ...
This milestone study, which aimed to evaluate the safety of the implant, use, and removal of the CBGM sensor lead, confirms the potential of this novel technology. The prospective study was ...
This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback